Author

Carl H. June

Primary ORCID profile (0000-0003-0241-3557 · 8 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Carl H. JuneiD8 papers · Abramson Cancer Center

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Charly R. Good· 1 shared Elena J. Orlando· 1 shared Karen Thudium Mueller· 1 shared Katharina E. HayeriD· 1 shared Marco RuellaiD· 1 shared Matthew D. WeitzmaniD· 1 shared Nathan Singh· 1 shared Olga Shestova· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Charly R. Good

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintMay 5, 2019

Impaired tumor death receptor signaling drives resistance to CAR T cell therapy

Nathan Singh, Olga Shestova, Pranali Ravikumar…·Marco Ruella

This study identifies impaired death receptor signaling as a driver of resistance to CAR T cell therapy in B-cell leukemia by showing its role in tumor survival and T cell dysfunction.

DOI 10.1101/627562

𝕏 PostBluesky